News

NEXTCHEM Partners with Röhm for Innovative Recycling Project

NEXTCHEM Partners with Röhm for Innovative Recycling Project

NEXTCHEM Collaborates with Röhm on PMMA Recycling Technology

NEXTCHEM has embarked on an exciting new project alongside Röhm, aiming to develop a feasibility study for a chemical plastic recycling plant. This plant will operate within Röhm's existing facilities and has the capability to process 5,000 tons per annum of Polymethyl Methacrylate (PMMA). The initiative underscores both companies' commitment to sustainability and innovation within the polymer industry.

NEXTCHEM's Advanced NXRe™ Technology

The heart of this project lies in NEXTCHEM's proprietary NXRe™ technology. This innovative approach has the potential to significantly reduce the carbon footprint associated with the production of methyl methacrylate (MMA) and its polymer counterpart, PMMA. Specifically, NXRe™ technology can achieve over 90% reduction in emissions compared to traditional production methods.

Strengthening the PMMA Circular Economy

This collaboration with Röhm is particularly important as it builds upon a partnership that aims to enhance the PMMA circularity network in Europe. Officially announced in late 2024, the partnership looks beyond mere recycling; it envisions a comprehensive solution for PMMA waste management, paving the way towards a more circular economy.

Significance of the Project

NEXTCHEM’s feasibility study signals a significant step in establishing a robust foundation for licensing its NXRe PMMA technology. The planned plant, fully integrated within Röhm's operations in Germany, is expected to play a critical role in their broader strategy of eliminating the incineration and landfill of PMMA-related production waste by 2030. This aligns perfectly with global efforts towards more sustainable materials and practices in the chemical industry.

Feedback from NEXTCHEM Leadership

Fabio Fritelli, Managing Director of NEXTCHEM, expressed his enthusiasm, stating, "Our NXRe™ PMMA technology is essential to our strategy for sustainable materials. This study represents a key advancement toward the industrialization of advanced recycling solutions and exemplifies the value of collaboration in fostering energy transitions. Together with Röhm, we are enhancing Europe's PMMA circularity network while driving innovation for a low-carbon future."

About MAIRE S.p.A.

MAIRE S.p.A. stands as a leading technology and engineering group, dedicated to propelling the energy transition forward. With a focus on Integrated Engineering & Construction Solutions in the downstream market and Sustainable Technology Solutions, MAIRE operates through three primary business streams: Sustainable Fertilizers, Low-Carbon Energy Vectors, and Circular Solutions. The company spans 50 countries worldwide and employs nearly 10,500 dedicated individuals, supported by approximately 50,000 professionals involved in various projects. MAIRE is publicly traded on the Milan Stock Exchange, with the ticker symbol MAIRE.

Frequently Asked Questions

What is the main focus of the NEXTCHEM and Röhm project?

The main focus is to develop a chemical plastic recycling plant that processes PMMA, utilizing the innovative NXRe™ technology.

How does the NXRe™ technology benefit PMMA production?

NXRe™ technology can significantly reduce the carbon footprint of PMMA production, achieving over 90% reduction in emissions compared to traditional methods.

When was the partnership between NEXTCHEM and Röhm announced?

The partnership aimed at enhancing PMMA circularity was announced in late 2024.

What is MAIRE S.p.A. known for?

MAIRE S.p.A. is known for its commitment to advancing the energy transition through innovative technology and engineering solutions in various sectors.

What is the capacity of the new recycling plant?

The new recycling plant will have a processing capacity of 5,000 tons of PMMA per annum, fully integrated with Röhm’s production infrastructure.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Concerns Rise Over Trump's Cryptocurrency Reserve Strategy

Updated Category News Views 192

Concerns About Cryptocurrency Announcements Prominent economist and market commentator Peter Schiff has urged a Congressional investigation into President Donald Trump's recent foray into cryptocurrency, suggesting that these announcements may involve insider trading and market manipulation. The Key Questions Raised In a recent post on X, Schiff sought answers to several...

Continue Reading
BriaCell Joins Prestigious Program to Boost Cancer Treatments

Updated Category News Views 145

BriaCell Enters MSK’s 2025 Therapeutics Accelerator Program BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, TSX: BCT) is thrilled to share the news of its selection into the Memorial Sloan Kettering Cancer Center (MSK) Therapeutics Accelerator Program for 2025. This prestigious program is designed to fast-track the clinical development of many innovative cancer...

Continue Reading
Exploring Current Net Asset Values of WisdomTree Funds

Updated Category News Views 114

Understanding Net Asset Value (NAV) in Investment Funds Net Asset Value (NAV) is a crucial metric for evaluating the performance of investment funds, representing the value of a fund's assets minus its liabilities. It's important for investors to keep track of NAV as it aids in making informed decisions regarding their investments. Here, we delve into the recent NAVs of...

Continue Reading
DoorDash's Innovative Tools Transforming Restaurant Dynamics

Updated Category News Views 208

Introduction to DoorDash's Expansion DoorDash (NASDAQ: DASH) has recently unveiled exciting developments regarding its Commerce Platform. This significant enhancement is set to assist restaurants in boosting direct sales while fostering better customer relationships across multiple channels. New Features for Restaurant Success The introduced tools are designed to uplift...

Continue Reading
Mezzion's Udenafil Shows Promise in ADPKD Study

Updated Category News Views 34

Positive News for Udenafil in Kidney Disease New updates from Mezzion Pharma Co., Ltd. have come across quite promising. They've reported some favorable results in a preclinical study of udenafil, targeting autosomal dominant polycystic kidney disease (ADPKD). It appears that this PDE5 inhibitor, typically used in aiding cardiovascular issues, now shows potential in...

Continue Reading